Analysts have been eager to weigh in on the Healthcare sector with new ratings on Concert Pharma (CNCE), Cellectar Biosciences (CLRB) and Inspire Medical Systems (INSP).
Concert Pharma (CNCE)
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Concert Pharma, with a price target of $17.00. The company’s shares closed last Wednesday at $6.70, close to its 52-week low of $5.47.
According to TipRanks.com, Fein is a 5-star analyst with an average return of 17.2% and a 52.8% success rate. Fein covers the Healthcare sector, focusing on stocks such as DBV Technologies SA – American, Constellation Pharmaceuticals, and Global Blood Therapeutics.
Concert Pharma has an analyst consensus of Strong Buy, with a price target consensus of $15.60, a 137.4% upside from current levels. In a report issued on February 26, Berenberg Bank also reiterated a Buy rating on the stock with a $11.00 price target.
See today’s analyst top recommended stocks >>
Cellectar Biosciences (CLRB)
H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Cellectar Biosciences today and set a price target of $3.00. The company’s shares closed last Wednesday at $1.86.
According to TipRanks.com, Ramakanth is a top 100 analyst with an average return of 39.6% and a 54.0% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Trillium Therapeutics, Harpoon Therapeutics, and Bicycle Therapeutics.
Cellectar Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $4.50, representing an 119.5% upside. In a report issued on March 2, Oppenheimer also maintained a Buy rating on the stock with a $5.50 price target.
Inspire Medical Systems (INSP)
In a report released today, Suraj Kalia from Oppenheimer assigned a Hold rating to Inspire Medical Systems. The company’s shares closed last Wednesday at $231.53, close to its 52-week high of $252.25.
According to TipRanks.com, Kalia is a 4-star analyst with an average return of 9.7% and a 55.9% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Cardiovascular Systems, and Edwards Lifesciences.
Currently, the analyst consensus on Inspire Medical Systems is a Moderate Buy with an average price target of $246.20.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on INSP:
